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Abstract
Background: Group B streptococci (GBS), or Streptococcus agalactiae, are the leading bacterial cause of
meningitis and bacterial sepsis in newborns. Here we compared different culture media for GBS detection and
we compared the occurrence of different genotypes and serotypes of GBS isolates from the vagina and rectum.
Methods: Streptococcus agalactiae was cultured separately from both rectum and vagina, for a total of 150
pregnant women, i) directly onto Columbia CNA agar, or indirectly onto ii) Granada agar resp. iii) Columbia CNA
agar, after overnight incubation in Lim broth.
Results: Thirty six women (24%) were colonized by GBS. Of these, 19 harbored GBS in both rectum and vagina,
9 only in the vagina and 8 exclusively in the rectum. The combination of Lim broth and subculture on Granada
agar was the only culture method that detected all GBS positive women. Using RAPD-analysis, a total of 66
genotypes could be established among the 118 isolates from 32 women for which fingerprinting was carried out.
Up to 4 different genotypes in total (rectal + vaginal) were found for 4 women, one woman carried 3 different
genotypes vaginally and 14 women carried two 2 different genotypes vaginally. Only two subjects were found to
carry strains with the same genotype, although the serotype of both of these strains was different.
Eighteen of the 19 subjects with GBS at both sites had at least one vaginal and one rectal isolate with the same
genotype.
We report the presence of two to four different genotypes in 22 (61%) of the 36 GBS positive women and the
presence of identical genotypes in both sites for all women but one.
Conclusion: The combination of Lim broth and subculture on Granada medium provide high sensitivity for GBS
detection from vaginal and rectal swabs from pregnant women. We established a higher genotypic diversity per
individual than other studies, with up to four different genotypes among a maximum of 6 isolates per individual
picked. Still, 18 of the 19 women with GBS from both rectum and vagina had at least one isolate from each
sampling site with the same genotype.
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Background
Streptococcus agalactiae, group B Streptococcus (GBS), is a
leading cause of neonatal morbidity and mortality in the
US, Western Europe and Australia. Maternal carriage has
been recognized as the most important risk factor for GBS
neonatal infection [1,2] and indeed vertical transmission
before or during delivery has been shown [3,4]. Motherto-child transmission may lead to neonatal infection in 1
to 2 infants per 1,000 live births [5] with mortality rates
ranging from 10 to 20% [6]. Among pregnant women, the
prevalence of colonization with GBS ranges from 3.2 to
36% [7-9]. Screening consists of obtaining vaginal and
rectal specimens for culture at 35 to 37 weeks of gestation.
Recently, several molecular techniques have been applied
to study the genetic diversity of GBS, such as restriction
fragment length polymorphism analysis (RFLP) [10],
ribotyping [10,11], pulsed-field gel electrophoresis
(PFGE) [3,12-17] multilocus enzyme electrophoresis
(MLEE) [18] randomly amplification of polymorphic
DNA-analysis (RAPD) [9,19,20], amplified cps restriction
polymorphism analysis [21] and multilocus sequence
typing (MLST) [13,22-25].
To our knowledge, only one study [12], addressed the
genotypic and serological diversity of GBS within individual women. Therefore, the aim of this study was to compare the genotypes of the GBS isolates from separate
vaginal and rectal swabs using a simple genotypic
approach (RAPD analysis with primer OPM1, followed by
capillary electrophoresis) and also to study the correlation
between serotype and genotype of the GBS isolates.

Methods
Study design
The study was approved by the research ethics committee
(IRB protocol nr 2007/096) of Ghent University Hospital,
Flanders, North region of Belgium, and all the women
gave written informed consent. Between April and
December 2007, 150 paired vaginal and rectal swabs were
collected from pregnant women at 35 - 37 weeks of gestation.
Collection and culture of specimens
All specimens were collected using nylon flocked swabs
that were submerged into 1 ml of liquid Amies transport
medium (eSwab, Copan Diagnostics, Brescia, It.). For rectal specimens, a swab was carefully inserted approximately 1.5 - 2 cm beyond the anal sphincter and then
gently rotated to touch anal crypts.

Vaginal samples were collected by inserting a swab into
the vagina. The swab was rolled round through 360
degrees against the vaginal wall at the midportion of the
vault. At Ghent University Hospital, the routine GBSscreening of pregnant women is always performed during
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the prenatal consultation at 35-37 weeks' gestation. All
study samples were collected by midwives and transported to the Laboratory of Bacteriology Research within
4 hours.
A total of 70 μl from the Amies liquid transport medium
of each of the vaginal and rectal swabs was seeded on
Columbia CNA agar with 5% sheep blood (Columbia
CNA agar, Becton Dickinson, Erembodegem, Belgium)
and 200 μl was inoculated into 5 ml of Lim Broth (ToddHewitt broth, 1% yeast extract, 15 μg nalidixic acid/ml
and 10 μg colistin/ml) (Lim Broth, Becton Dickinson)
[26]. Both media are selective for Gram positive bacteria.
The Columbia CNA agar plates were incubated at 37°C in
5% CO2 for 24-48 h.
The Lim Broth was incubated aerobically at 37°C for 1824 hours and then subcultured onto Granada agar (Becton Dickinson) [27] and onto Columbia CNA agar. Granada agar was incubated at 37°C in an anaerobic chamber
(BugBox, LedTechno, Heusden-Zolder, B.) for 24-48 h
and Columbia CNA agar was incubated at 37°C in 5%
CO2 for 24-48 h.
Granada agar was examined for yellow-orange pigment
colonies that confirm the presence of GBS, whereas βhaemolytic and non-haemolytic colonies were picked
from Columbia CNA agar for further identification as S.
agalactiae by the CAMP test.
Identification of the isolates as Streptococcus agalactiae
The isolates were identified as S. agalactiae by the following criteria: growth and orange pigment formation on
Granada agar, positive for the CAMP test on blood agar
and molecular identification by tDNA-PCR [28].
Antibiotic susceptibility testing
Fourty isolates of group B streptococci of 8 pregnant
women were tested by disk diffusion for susceptibility to
clindamycin and erythromycin Colonies taken from Trypticase Soy Agar (TSA) + 5% sheep blood (Becton Dickinson) were suspended in 5 ml of saline and the inoculum
was adjusted to the turbidity of a 0.5 McFarland standard.
This suspension was streaked onto TSA + 5% sheep blood
to obtain confluent growth, disks were added and the
plates were incubated overnight at 37°C with 5% CO2.
Strains were considered resistant to clindamycin and
erythromycin when the inhibition zones were less than 15
mm.
DNA-extraction from isolates
DNA was extracted from cultured isolates by alkaline lysis
as follows: One bacterial colony was suspended in 20 μl
of lysis buffer (0.25% sodium dodecyl sulfate, 0.05 N
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NaOH) and heated at 95°C for 15 min. The cell lysate was
diluted by adding 180 μl of distilled water. The cell debris
was spun down by centrifugation at 16,000 g for 5 min.
Supernatants were used for PCR or frozen at -20°C until
further use.

using the differential basepairs (dbp) and the Dice algorithm [30]. Clustering analysis was done with the Phylip
software
http://evolution.genetics.washington.edu/
phylip.html, using the Neighbor Joining algorithm.
Serotyping
A total of 122 GBS isolates from 36 pregnant women were
serotyped, using the latex co-agglutination kit of Essum
AB (Umea, Sweden), according to the manufacturer's
instructions. This kit enables to differentiate between
serotypes Ia, Ib, II, III, IV and V.

Genotyping of isolates
The cultured vaginal and rectal GBS isolates were genotyped using RAPD-analysis with the RAPD Ready-to-Go
beads (GE Healthcare. Buckinghamshire, UK) as
described previously [29] with primer OPM1 (5' GTT GGT
GGC T) at a final concentration of 2 μM, including 0.2 μM
of fluorescent TET-labeled OPM1 primer. After 5 min at
94°C, 5 min at 35°C and 5 min at 72°C, reaction mixtures were cycled 30 times in a Veriti™ Thermal Cycler
(Applied Biosystems, Foster City, Ca.), with the following
conditions: 30 s at 94°C, 1 min at 35°C, and 1 min at
72°C, with a final extension period of 5 min at 72°C.
Reaction vials were then cooled to 10°C and kept on ice
until electrophoresis.

Statistical methods
The McNemar test for correlated percentages was used to
compare the sensitivity of the culture media.

Results
For a total of 150 women, culture was carried out separately for both rectal and vaginal sites, using three culture
methods, i.e. directly onto Columbia CNA agar, or indirectly, by subculturing onto Columbia CNA agar resp.
Granada agar, following overnight incubation in LIM
broth.

Capillary electrophoresis
A volume of 11.9 μl of deionized formamide (ACE formamide, Lucron, De Pinte) was mixed with 0.6 μl of an internal size standard mixture containing 0.3 μl of the ROX400 high-density size standard (Applied Biosystems, Foster City, Ca.) and 0.3 μl of Map marker 1000 size standard
(BioVentures, Murfreesboro, Tn.). One microliter of
OPM1-PCR product was added. The mixtures were denatured by heating at 95°C for 3 min and placed directly on
ice for at least 10 min. Capillary electrophoresis was carried out using an ABI-Prism 310 genetic analyzer (Applied
Biosystems) at 60°C, at a constant voltage of 1.5 kV, and
at a more or less constant current of approximately 10 mA.
Capillaries with a length of 47 cm and diameter of 50 μm
were filled with performance-optimized polymer 4. Electropherograms were normalized using Genescan Analysis
software, version 2.1 (Applied Biosystems).

Comparison of culture techniques
A total of 36 out of 150 pregnant women studied (24%)
were colonized by GBS. Of 55 samples from which GBS
was isolated, 22 were positive by direct inoculation on
Columbia CNA agar, 55 by Lim broth enrichment with
subculture on Granada agar and 45 by Lim broth with
subculture on Columbia CNA agar, resulting in sensitivities of 40, 100 and 81% respectively (Table 1).

Culture of vaginal specimens by direct plating on Columbia CNA agar was significantly less sensitive than culture
in Lim broth with subculture on Granada agar or subculture on Columbia CNA agar (McNemar test, p < 0.0001).
In addition, the culture of rectal specimens, direct plating
onto Columbia CNA agar was significantly less sensitive
than culture in Lim broth with subculture on Granada
agar (p < 0.0001), which was more sensitive than culture
on Lim broth with subculture on Columbia CNA agar (p
= 0.0313).

Data analysis
OPM1-PCR fingerprints were obtained as table files from
the Gene Scan Analysis software and used in a software
program developed at our laboratory [30]. Using these
sample files composed of numbers, representing the
length of the amplification fragments in base pairs, a distance matrix was calculated with the in-house software

Table 1: Number of GBS-positive cultures detected by different culture media in separate vaginal and rectal specimens obtained from
150 pregnant women

Specimen No. of positive GBS cultures detected by
Columbia CNA agar Lim broth + Granada agar Lim broth + Columbia CNA agar Total no. of women colonized
Vaginal
Rectal
Total

11
11
22

28
27
55

24
11
45

28
27
36
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Carriage of GBS and genotyping
For the 36 women that were found positive, 9 (25%) carried GBS only in the vagina, 8 (22%) only in the rectum
and 19 (53%) in both sampling sites (Table 1). Using
three culture methods for two sampling sites, a maximum
of 6 colonies per woman was picked, one from each of the
positive culture plates. A total of 122 isolates were
obtained (Table 2) of which 118 were genotyped using
RAPD with primer OPM1 and analysis by capillary electrophoresis. The single isolates from four women were not
fingerprinted, because there were no other isolates from
the same subject to compare with. A tree was constructed
after distance matrix calculation, and this revealed the
presence of a total of 66 genotypes among the 118 isolates

from 32 women for which fingerprinting was carried out.
Only two subjects (RVS033 and RVS062) were found to
carry strains of which the RAPD genotype was indistinguishable (Figure 1).
For 5 out of the 19 women from which both vaginal and
rectal isolates were obtained, all the rectal and vaginal isolates were identical. For another 13 of these 19, at least
one of the vaginal isolates had a similar genotype as one
of the rectal isolates. Four women had two genotypes,
seven had three genotypes and three had four genotypes.
One of the five women with only rectal isolates had one
genotype, whereas the other four had two genotypes. For
the eight women with only vaginal isolates, four of them

Table 2: Overview of genotyping and serotyping results for 36 women positive for GBS.

Number

Number

V DC

V LG

V LC

R DC

R LG

R LC

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36

RVS143
RVS038
RVS071
RVS073
RVS109
RVS034
RVS035
RVS076
RVS148
RVS004
RVS051
RVS080
RVS084
RVS021
RVS061
RVS120
RVS145
RVS017
RVS047
RVS106
RVS127
RVS069
RVS039
RVS083
RVS114
RVS123
RVS027
RVS033
RVS064
RVS075
RVS110
RVS126
RVS136
RVS031
RVS062
RVS074

A/III
B/III
A/Ib
A/II
A/IV
A/V
A/III
A/III
A/V
A/NT
B/Ib

+a/Vb
A/III
A/IV
A/III
A/V
B/Ib
A/II
B/Ib
A/III
A/IV
A/IV
A/II
A/IV
A/NT
A/Ia
A/III
B/V
A/NT
A/V
C/III
B/III
B/II
A/V
C/IV
A/NT
D/III
D/II
A/Ib

A/V
A/IV
A/V
A/V
A/II
B/Ib
B/III
A/IV
A/IV
A/IV
A/Ia
B/Ib
A/V
A/NT
C/V
A/III
A/III
A/II
A/V
A/NT
B/III
A/III
A/II
D/Ib

B/Ia
B/V
A/IV
A/II
A/III
A/V
A/III
A/III
C/V
B/NT
B/Ib

+/Ia
+/V
+/IV
A/NT
A/Ib
A/NT
A/Ia
A/Ia
A/IV
A/IV
A/II
A/IV
A/NT
B/Ia
A/III
A/V
A/NT
A/V
B/III
C/III
C/II
B/V
B/IV
A/NT
A/III
B/II
A/Ib

A/NT
A/Ib
A/NT
B/Ia
B/V
A/IV
A/IV
A/Ia
A/III
A/V
B/NT
B/V
A/III
A/III
A/II
A/V
A/NT
C/NT
C/II
C/II
C/Ib

Column headings: V DC: Vaginal sample, cultured directly on Columbia Agar, V LG: after Lim broth enrichment culture, plated onto Granada agar,
V LC: after Lim broth enrichment culture, plated onto Columbia agar; R DC: Rectal sample, idem as for vaginal samples.
-: No GBS isolated.
a: Genotype: +: strain present, but not genotyped, A, B, C, D: genotypes numbered per individual.
b: Serotype: serotype number as determined by the Essum AB kit (Umea, Sweden). The following serotypes can be detected by this kit: Ia, Ib, II, III,
IV and V. NT: nontypeable.
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types 1 of two isolates from two different subjects (RVS033 and RVS062) showing the same genotype and different seroFingerprints
Figure
Fingerprints of two isolates from two different subjects (RVS033 and RVS062) showing the same genotype and
different serotypes. x-axis: length of amplified DNA fragments expressed in bps. y-axis: peak height (intensity of DNA-fragment).
had only one genotype and the other four had two genotypes.
Serotyping
In addition, all isolates were serotyped (Table 2). Seventeen isolates, from 7 subjects, were nontypeable. Furthermore, a rather equal distribution of the serotypes was
found among the strains (Table 2). Eight women were
found to carry isolates of the same genotype and serotype.
An example is shown in Figure 2. In 11 subjects, only one
serotype was present, although 2 to 4 genotypes could be
found per subject. Nine subjects were found to carry isolates with different genotype and different serotype (Figure 3). The two isolates with the same genotype from the
two different subjects belonged to different serotypes.

The frequency of different serotypes was as follows Ia:
10.4%, Ib: 10.4%, II: 10.4%, III: 20.8%, IV: 12.5, V: 20.8
and nontypeable: 14.5%. Overall serotype distribution
among vaginal vs rectal isolates was comparable, with a
rectal predominance of Ia, i.e. 1 vaginal isolate vs 5 rectal
isolates and a vaginal predominance of III, i.e. 10 vaginal
isolates vs 4 rectal isolates. The presence of L. crispatus,
generally accepted to confer vaginal colonisation resistance to pathogenic organisms [31,32], did not seem to
protect against vaginal S. agalactiae colonization, since a
comparable number of women colonized only vaginally
by S. agalactiae resp. only rectal by S. agalactiae were colonized vaginally by L. crispatus, i.e. 3/9 resp. 2/8. Six of the
19 women colonized by S. agalactiae both rectally and
vaginally carried L. crispatus vaginally.
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Figure 2 of different isolates of subject RVS047 with the same genotype and the same serotype
Fingerprints
Fingerprints of different isolates of subject RVS047 with the same genotype and the same serotype. x-axis:
length of amplified DNA fragments expressed in bps. y-axis: peak height (intensity of DNA-fragment).

Antibiotic susceptibility testing
GBS is considered homogenously susceptible to penicilline and amoxicillin. In case of allergy, second choice antibiotics are clindamycin or erythromycin. According to
CLSI erythromycine can be tested with a simple disk test,
although this is not done in our routine laboratory. Here
we checked 40 isolates from 8 patients and found 26 isolates to be susceptible to both clindamycine and erythromycine, 3 to be clindamycine resistant and 11 to be
resistant to both antibiotics. The susceptibility pattern of
all strains was homogeneous for six subjects, despite genotypic differences among the isolates, whereas two subjects carried clindamycin resistant strains besides isolates
susceptible to both antibiotics.

Discussion
Sensitivity and specificity of different culture techniques
for the detection of GBS
In our study, only the combination of Lim broth and subculture on Granada agar enabled detection of all carriers,
whereas direct inoculation onto Columbia CNA agar
achieved a sensitivity of 40% and subculture of the Lim
broth onto Columbia CNA agar detected 81% of the carriers.

Gil et al. [33] showed that in different studies the sensitivity of Granada agar ranged from 88.5 to 91.1%, that of
Columbia CNA agar from 83.9 to 94.3% and that of Lim
broth (to which 5% horse serum was added) was 63.5%
when subcultured on Granada agar and 75% when subcultured on Columbia CNA agar. Bosch-Mestres et al. [34]
showed that the use of direct inoculation onto Granada

Page 6 of 11
(page number not for citation purposes)

BMC Infectious Diseases 2009, 9:153

http://www.biomedcentral.com/1471-2334/9/153





















































































































































































Figure 3 of different isolates of subject RVS031 with different genotypes and different serotypes
Fingerprints
Fingerprints of different isolates of subject RVS031 with different genotypes and different serotypes. x-axis:
length of amplified DNA fragments expressed in bps. y-axis: peak height (intensity of DNA-fragment).

agar allowed fast detection for about 87% of carriers,
where as the combination of Todd-Hewitt broth and subculture on Granada agar or Columbia CNA agar allowed
detection of more than 99% of GBS carriers. Elsayed et al.
[35] reported 79% sensitivity for direct inoculation onto
Columbia CNA agar and incubation during 48 hours
compared to 100% sensitivity for Lim broth with subculture on blood agar. It can be concluded from this study
and others that the combination of broth enrichment
(Todd-Hewitt or LIM broth) with subculture on solid
medium, yields higher sensitivity than direct inoculation
onto solid media.
Although no definite conclusions can be drawn with
regard to the sensitivity of the different solid media, Granada agar has the advantage that it makes possible to provide overnight results by visual inspection of the presence

of red orange colonies, that are produced exclusively by
GBS. The red orange colonies are easily observed, even
when few colonies are present or when GBS is mixed with
other microorganisms, which are mainly other streptococci [33] . The colonies are so characteristic and unique
that identification by antigen detection or the CAMP test
is unnecessary. In this study, all red orange colonies were
CAMP positive (data not shown). Claeys et al. [36] missed
only two CAMP positive isolates on a total of 310 tested,
which were not red orange pigmented on Granada.
Blanckaert et al. [37] used a combination of Granada and
Columbia blood agar for GBS screening and demonstrated that 6% of the samples positive for GBS on Columbia blood agar lacked red orange colonies on Granada
agar. Notably, Granada agar does not detect non-pigmented isolates, and on blood-agar these non-hemolytic
isolates are difficult to detect as well. As a result of that,
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non hemolytic, nonpigmented strains may have been
missed. In conclusion, in our hands, the use of combination of Lim broth and subculture on Granada agar provided high sensitivity and specificity for detecting GBS in
vaginal and rectal swabs from pregnant women.
Epidemiology
The high prevalence of S. agalactiae colonization, i.e. 24%,
as established in this study, is in accordance with results
from other European studies that report colonization
rates between 10% and 36% [38-43]. Thinkhamrop et al.
[44] reported a prevalence of 7.1% (Myanmar) to 19.1%
(Philadelphia), using Lim broth culture. Toresani et al. [9]
found a prevalence of only 3.2% among 531 Argentinan
pregnant women. Brimil et al. [38] showed equal carrier
rates of 16% for GBS among pregnant and nonpregnant
women and, based on the prevalence of GBS carriage,
these authors concluded that strict adherence to the guidelines for prevention of GBS neonatal infection results in
peripartal antibiotic prophylaxis in up to 20% of all deliveries.

Our data, are also in correspondence with other results on
GBS prevalence in our country. Rectovaginal colonization
with group B streptococci in Belgium is 13-25%. These
data are based on different studies carried out by the Belgian reference laboratory for GBS in collaboration with
the section of epidemiology of the Scientific Institute for
Public Health (ISP-WIV, Brussels) [45]. For example,
Blanckaert et al. [37] compared the results of GBS screening on Granada agar with those obtained using standard
Columbia blood agar at two participating centers in Belgium. They reported GBS-positive culture results of 1030% of pregnant women. The Flemish Study Centre for
Perinatal Epidemiology evaluated GBS prevalence in Flanders and found an average colonization rate of 16%
among Flemish pregnant women [46].
Manning et al. [41] found that the prevalence of GBS colonization was equally high among 241 women (34%)
and 211 men (20%) living in a college dormitory. Sexually experienced subjects had twice the colonization rates
of sexually inexperienced participants. Van der Mee-Marquet et al. [47] reported that the prevalence of carriage was
27% in women and 32% in men. The major positive body
site was the genital tract (23% in women and 21% in
men) and skin, throats, and anal margins were also positive in 2%, 4%, and 14%, respectively.
Comparison between vaginal and rectal carriage
Brimil et al. [38] reported that for a total of 34 GBS positive pregnant women, 32% carried GBS only vaginal, 24%
only rectal and 44% both rectal and vaginal, which compares well with our results, i.e. resp. 24%, 22% and 53%.

http://www.biomedcentral.com/1471-2334/9/153

Serotypic and genotypic diversity among GBS isolates
We studied the rectal and vaginal colonization with GBS
of pregnant women attending the Ghent University hospital (Belgium) and the serotypic and genotypic diversity
among the GBS isolates. Strong genotypic and serotypic
heterogeneity was observed between women and for individual women, e.g., we found a total of 66 genotypes
among 118 isolates (from 32 women), of which 4 women
had up to 4 different genotypes in total (rectal + vaginal)
and 14 women had up to 2 different genotypes vaginally.

Manning et al. [48] genotyped GBS isolates from vaginalrectal swabs of women at two visits and documented a
turnover in 8.3% of 126 women colonized both at 35-37
weeks of gestation and 6 weeks after delivery. Unfortunately, only one isolate was genotyped per visit. Taking
into consideration the genotypic diversity per subject, as
observed in our study, a turnover of 8.3% might be an
overestimation. When the same subject, carrying e.g. genotypes a, b and c, is sampled at two different moments,
and whereby on each occasion only one colony is picked,
the detection of a different genotype may be interpreted as
turn over, but it may be that a genotype a strain has picked
at the first visit but a genotype b or c strain at the second
visit.
Moreover, their conclusion that some clones are more
likely to be lost should be interpreted with care, since their
apparent disappearance might be explained by the presence of these clones in relatively lower numbers (compared to other clones), which reduces their chance of
being picked at two separate occasions. To our knowledge,
only one group studied genotypic diversity within individual women, by genotyping 15 randomly picked isolates for each of 30 women, albeit from mixed vaginalrectal specimens [12]. In opposition to our results, these
authors found a high degree of genotypic and serotypic
homogeneity, i.e. for 29 of 30 women, all 15 isolates from
each woman had the same serotype, and for 27 of 30
women, all 15 isolates had the same chromosomal SmaIDNA restriction digest fingerprint. For the three women
with different PFGE types, one had three different genotypes and two different serotypes. Another PFGE based
study reported high stability of the GBS type for each
woman, followed up to two years [40]. In accordance with
our results, these authors found 30 different GBS isolates
among 32 women, with only two women carrying isolates
with the same genotype.
The high level of heterogeneity established in our study,
compared to other studies, may be due to the different
culture media that were used and to the use of separate
swabs for sampling vagina and rectum for each individual
woman. We found that strains of the same serotype recovered from different women were heterogeneous in DNA
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profiles. In accordance, SmaI-restriction digestion of chromosomal DNA and PFGE revealed high genotypic heterogeneity among both Zimbabwean serotype III and
serotype V isolates [16], another study also reported different SmaI restriction types within serotypes II and V
[12], and Fasola et al. [14] and Savoia et al. [49] showed
that several genotypic lineages are present within the different serotypes.
Serotype switching is believed to occur within genotypic
lineages [7,24,25], presumably by horizontal transfer of
genes of the cps locus, i.e. of genes encoding the GBS capsular polysaccharide structure [50], and may be an explanation for our observation of the presence of two isolates
in two different women with the same genotype, but with
a different serotype.
Although MLST has become the standard method to study
the population structure of GBS [22,24], more rapid and
less expensive and laborious methods remain useful for
carrying out single centre studies. We used RAPD-analysis
in combination with high resolution capillary electrophoresis, which also makes possible immediate digitization of the fingerprints. Chatellier et al. [51] found that the
simplest typing scheme of S. agalactiae was obtained by
the combination of RAPD typing and serotyping (discriminatory index 0.97). Zhang et al. [20] found congruence
between RAPD analysis and serotyping, on a limited
number of strains. The findings of Toresani et al. [9], who
found a total 16 RAPD profiles among 21 GBS isolates,
from 17 women, and of Chatellier et al. [51], who identified 71 RAPD types among 54 unrelated S. agalactiae
strains isolated from cerebrospinal fluid samples from
neonates, point to the same genotypic diversity as
observed in our study.
General serotype distribution
The capsule of S. agalactiae has long been recognized as
one of the most important virulence factors. Variations of
the capsular polysaccharide structure allow the antigenic
distinction of 13 different S. agalactiae serotypes, of which
9 are of clinical importance (Ia, Ib, II-VIII). Studies from
the US and Europe show that the serotypes Ia, II, III, and
V are found in 80-90% of all clinical isolates [4,48].

Serotype distribution among GBS isolates from pregnant
women in our study was compared with that reported by
others. Several studies indicate that serotype III is globally
the most prevalent serotype, e.g. 29.2% of Israelian isolates [7], 28% of German isolates [38], 24.3% of Swedish
isolates [39] and 33.2% of Czech isolates [42]. In accordance, we observed a frequency of 20.8% for serotype III
isolates in our study, as the most frequent serotype.
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Antibiotic susceptibility
The finding that two out of 8 women carried isolates with
different susceptibility to clindamycin indicates that when
testing susceptibility for clindamycin several colonies
should be tested, since colonies with different susceptibility may be simultaneously present.

Conclusion
In summary, our study, including 150 pregnant women,
confirmed the European prevalence of around 20% of
GBS among pregnant women and the predominance of
serotypes III and V among these women, but we established a higher genotypic diversity per individual than
other studies, with up to four different genotypes among
a maximum of 6 isolates per individual picked. Still, 18 of
the 19 women with GBS from both rectum and vagina
had at least one isolate from each sampling site with the
same genotype. In our hands, the combination of Lim
broth and subculture on Granada medium provided
higher sensitivity than direct culture on Columbia CNA or
Lim broth and subculture on Columbia CNA for GBS
detection from vaginal and rectal swabs from pregnant
women.
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